Correlation Between Microsoft and Olema Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Microsoft and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and Olema Pharmaceuticals, you can compare the effects of market volatilities on Microsoft and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Olema Pharmaceuticals.

Diversification Opportunities for Microsoft and Olema Pharmaceuticals

0.52

Correlation Coefficient

Microsoft  Olema Pharmaceuticals

Very weak diversification

The 3 months correlation between Microsoft and Olema is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Microsoft i.e., Microsoft and Olema Pharmaceuticals go up and down completely randomly.

Pair Corralation between Microsoft and Olema Pharmaceuticals

Given the investment horizon of 90 days Microsoft is expected to generate 8.55 times less return on investment than Olema Pharmaceuticals. But when comparing it to its historical volatility, Microsoft is 2.27 times less risky than Olema Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,202  in Olema Pharmaceuticals on August 14, 2024 and sell it today you would earn a total of  70.00  from holding Olema Pharmaceuticals or generate 5.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Microsoft  vs.  Olema Pharmaceuticals

Microsoft

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Microsoft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Olema Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Olema Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Olema Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Microsoft and Olema Pharmaceuticals

The main advantage of trading using opposite Microsoft and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.

The idea behind Microsoft and Olema Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.